블로그
- Dextran 110, MW: 100,000 to 120,000 [OD156909][CAS no. 9004-54-0]_Biosynth - 코아사이언스 This compound has been shown to be effective in the treatment of chronic schizophrenia, with clinical studies showing that it may be more effective than other anti-schizophrenia drugs. (2E)-3-Methyl-2-hexenoic
- Schizoaffective disorders Schizophrenia - a devastating disease of the brain that affects a person's thinking, language, emotions severe and more negative symptoms - comorbid mental health diseases are common such as depression or